Chairman, President and CEO Steve Rusckowski participates in a health care discussion at the 2017 World Economic Forum Annual Meeting

Diagnostics & Health Care at the World Economic Forum


Quest Diagnostics CEO Steve Rusckowski participates in the WEF healthcare discussions

NY Giants Mark Herzlich Uses Lab Testing to Achieve Excellence


Heading into the playoffs the linebacker uses Blueprint for Athletes to gain insights.

Quest CEO Discusses Future Path with Modern Healthcare


Steve Rusckowski discusses the company’s goals and future and more in a Q&A with Modern Healthcare.

Quest Rings NYSE Closing Bell


In advance of our 20th anniversary of being listed on the New York Stock Exchange and our 50th anniversary as a company, on November 14, Quest Diagnostics President and CEO Steve Rusckowski was joined in New York by employees from around the country to ring the closing bell. Along with the 4 p.m. ceremony that […]

Quest Discusses Accelerating Growth, Operational Excellence with Investors


Members of the Quest Diagnostics senior management team present the company’s new two-point strategy to analysts and investors.

The Future of Precision Medicine Begins Today


IBM Watson Genomics from Quest Diagnostics combines genomic sequencing expertise with Watson-powered cognitive computing to inform precision treatment and clinical trial options for cancer patients.

OncoKB: An Interactive Online Knowledge Base to Democratize Access to Cancer Gene Mutation Information

Better Health

Data sharing is emerging as an important part of cancer diagnosis and treatment, and is even an imperative of Vice President Biden’s Cancer Moonshot program.

AACC: Highlighting the Latest Data & Engaging with the Scientific Community


Quest Diagnostics presents at the 68th American Association for Clinical Chemistry Annual Scientific Meeting & Clinical Lab Expo in Philadelphia.